The effect of aspirin, ticlopidine and their low-dose combination on platelet aggregability in acute ischemic stroke: A short duration follow-up study

European Journal of Neurology

Volumn 6, Issue 1, 1999, Pages 57-61

  Akyüz, Aytekin ^a   Bolayir, Ertugrul ^a   Dener, Sefik ^a   Topalkara, Kamil ^a   Topaktas, Suat ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Aspirin; Aspirin plus ticlopidine; Platelet aggregation; Stroke; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE; THROMBOCYTE AGGREGATION;

EID: 0033002959     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.610057.x     Document Type: Article

References (17)

1. Bellavance A (1993). Efficacy of ticlopidine and aspirin for the prevention of reversible cerebrovascular ischemic events. Ticlopidine Aspirin Stroke Study 24(10):1452-1457.
2. Benner KU, Geeren M, Burstedde V, Eveerts B (1984). Platelet aggregation abnormalities in arterial occlusive diseases (AOD). J Med 15(1):23-34.
3. Couch JR, Hassanein RS (1976). Platelet aggregation, stroke and transient ischemic attack in middle-aged and elderly patients. Neurology 26:888-895.
4. Diener HC (1998). Antiplatelet drugs in secondary prevention of stroke. Int J Clin Pract 52(2):91-97.
5. Gent M, Blakely JA, Easton JD, Ellis DJ, Harbinson JW, Hachinsky VC et al. (1989). The Canadian-American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1:1215-1220.
6. Grotemeyer KH, Bork G, Leonhardt M (1985). Duration of the effect of acctylsalicylic acid on circulating platelet aggregates in cerebral infarct patients. Fortschr Neurol Psychiatry 53(9):350-353.
7. van Kooten F, Ciabattoni G, Patrono C, Schmitz PIM, van Gijn J, Koudstaal (1994). Evidence for episodic platelet activation in acute ischemic stroke. Stroke 25(2):278-281.
8. Koudstaal PJ, Ciabattoni G, Van Gijn J, Nieuwennuis HK, de Groot PG, Siixma JJ, Patrona C (1993). Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke 24(2):219-223.
9. Lee TK, Chen YC, Kuo TL (1987). Comparison of the effect of acctylsalicylic acid on platelet function in male and female patients with ischemic stroke. Thromb Res 47(3):295-304.
10. Neumann FJ, Gawaz M, Dickfeld T, Wehinger A, Walter H, Balsini R, Schomig A (1997). Antiplatelet effect of ticlopidine after coronary stenting. J Am Coll Cardiol 29(7):1515-1519.
11. Rohrer TF, Pfister B, Weber C, Imhof PR, Stucki P (1978). Validity of Wu-Hoak method for quantitative determination of platelet aggregation in vivo. Blut 36(1):15-20.
12. Schellinger PD, Orberk E, Hacke W (1997). Antithrombotic therapy after cerebral ischemia. Fortschr Neurol Psychiatry 65(9):425-434.
13. Uchiyama S, Sone R, Nagayama T, Shibagaki Y, Kobayashi I, Maruyama S, Kusakabe K (1989). Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia. Stroke 20(12):1643-1647.
14. Watanabe K, Ono F (1992). Current status and problems of platelet function tests. Rinsho Byori 40(5):507-514.
15. Weksler BB (1992). Platelet function and antiplatclet therapy in ischemic cerebrovascular disease. In: Stroke: pathophysiology, diagnosis and management. Barnett HJM (editor). New York, Churchill Livingstone Inc. pp 913-917.
16. Winkler J, Fuchs J, Morduchowicz G, Boner G, Sulkiss J, Weinberger I (1997). Circulating aggregated platelets, number of platelets per aggregate and platelet size in chronic dialysis patients. Nephron 77(1):44-47.
17. Wu KK, Hoak JK (1974). A new method tor the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 19:924-926.